Scarica l'app Stockscreener
65.26
1.58%
-1.05
Pre-mercato:
65.27
0.010
+0.02%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DXCM Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$66.31
Aprire:
$65.65
Volume 24 ore:
5.29M
Relative Volume:
1.04
Capitalizzazione di mercato:
$25.12B
Reddito:
$4.66B
Utile/perdita netta:
$836.30M
Rapporto P/E:
31.18
EPS:
2.093
Flusso di cassa netto:
$1.08B
1 W Prestazione:
-7.68%
1M Prestazione:
+0.28%
6M Prestazione:
-14.38%
1 anno Prestazione:
-7.77%
Intervallo 1D:
$65.17
$66.79
Intervallo di 1 settimana:
$65.17
$69.86
Portata 52W:
$54.11
$89.98
Dexcom Inc Stock (DXCM) Company Profile
Nome
Dexcom Inc
Settore
Industria
Telefono
(858) 200-0200
Indirizzo
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
65.26 | 25.12B | 4.66B | 836.30M | 1.08B | 2.093 |
|
ABT
Abbott Laboratories
|
108.14 | 187.91B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
337.21 | 129.05B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.38 | 112.19B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.55 | 101.72B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.61 | 49.14B | 6.07B | 1.06B | 1.34B | 1.8063 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-12 | Downgrade | Barclays | Equal Weight → Underweight |
| 2025-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | Iniziato | Evercore ISI | In-line |
| 2025-10-21 | Ripresa | Stifel | Buy |
| 2025-09-08 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-08-21 | Iniziato | Argus | Buy |
| 2025-06-16 | Iniziato | Truist | Buy |
| 2025-05-30 | Iniziato | Goldman | Buy |
| 2025-04-10 | Iniziato | Mizuho | Outperform |
| 2025-02-03 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | Iniziato | Redburn Atlantic | Neutral |
| 2024-03-12 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-04-17 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2023-01-26 | Iniziato | Wolfe Research | Outperform |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-15 | Iniziato | Bernstein | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-03 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-01-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2021-10-18 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-28 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2021-01-06 | Aggiornamento | UBS | Neutral → Buy |
| 2020-10-02 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | Reiterato | Piper Sandler | Overweight |
| 2020-05-14 | Iniziato | Wells Fargo | Equal Weight |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-11-07 | Reiterato | Canaccord Genuity | Buy |
| 2019-11-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-10-23 | Iniziato | Stifel | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-10-19 | Aggiornamento | Goldman | Sell → Neutral |
| 2018-09-12 | Aggiornamento | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | Reiterato | Canaccord Genuity | Buy |
| 2018-07-02 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-05-11 | Iniziato | BofA/Merrill | Buy |
| 2018-05-03 | Reiterato | Canaccord Genuity | Buy |
| 2018-04-04 | Iniziato | Goldman | Sell |
| 2018-04-04 | Iniziato | Guggenheim | Neutral |
| 2018-03-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | Downgrade | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | Reiterato | Wedbush | Outperform |
Mostra tutto
Dexcom Inc Borsa (DXCM) Ultime notizie
Mizuho raises DexCom (DXCM) price target to $90 from $78 after earnings beat - MSN
Swiss National Bank Trims Stake in DexCom by 4.8% - National Today
Swiss National Bank Sells 56,600 Shares of DexCom, Inc. $DXCM - MarketBeat
Mackenzie Financial Corp Raises Position in DexCom, Inc. $DXCM - MarketBeat
Capital Research Global Investors Trims Holdings in DexCom, Inc. - National Today
Capital Research Global Investors Cuts Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
Analysts Set DexCom, Inc. (NASDAQ:DXCM) PT at $85.18 - National Today
Is DexCom (DXCM) Quietly Reframing Its Innovation Moat With New Boardroom Tech Expertise? - simplywall.st
Sands Capital Management LLC Lowers Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
WINTON GROUP Ltd Lowers Position in DexCom, Inc. $DXCM - MarketBeat
Citigroup Adjusts Price Target on DexCom to $84 From $77, Maintains Buy Rating - marketscreener.com
First Trust Advisors LP Boosts Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026 - Morningstar
Investigation announced for Long-Term Investors in shares of DexCom, Inc. (NASDAQ: DXCM) - openPR.com
2 Growth Stocks to Hold for the Next Decade - The Motley Fool
DexCom Inc (NASDAQ:DXCM): A Prime Example of Growth at a Reasonable Price - ChartMill
Here's Why DexCom (DXCM) is a Strong Growth Stock - Yahoo Finance
DexCom (NASDAQ:DXCM) Given Buy Rating at BTIG Research - MarketBeat
Demystifying DexCom: Insights From 12 Analyst Reviews - Benzinga
Rathbones Group PLC Reduces DexCom Stake by 79.9% - National Today
Rathbones Group PLC Has $9.32 Million Position in DexCom, Inc. $DXCM - MarketBeat
Korea Investment CORP Has $51.79 Million Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
Bell Asset Management Ltd Buys Shares of 31,448 DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Shares Sold by Alamar Capital Management LLC - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Can DexCom Inc. stock resist market sell offs2026 Opening Moves & Smart Investment Allocation Tips - Naître et grandir
Neuberger Berman Group LLC Buys 324,849 Shares of DexCom, Inc. $DXCM - MarketBeat
Blair William & Co. IL Lowers Holdings in DexCom, Inc. $DXCM - MarketBeat
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know - Yahoo Finance
A Look At Dexcom (DXCM) Valuation After Recent Share Price Swings - Yahoo Finance
Is DexCom Stock Underperforming the Nasdaq? - Yahoo Finance
Fisher Asset Management LLC Sells 23,056 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom: Gaining Favor, With Useful Tailwinds To Support It Even Further (NASDAQ:DXCM) - Seeking Alpha
Picton Mahoney Asset Management Acquires 26,106 Shares of DexCom, Inc. $DXCM - MarketBeat
CI Investments Inc. Increases Position in DexCom, Inc. $DXCM - MarketBeat
Elo Mutual Pension Insurance Co Has $3.66 Million Stock Position in DexCom, Inc. $DXCM - MarketBeat
Dexcom Executive Chairman Kevin Sayer Returns From Leave - The Globe and Mail
How Adding Google’s Rick Osterloh To Dexcom’s Board (DXCM) Could Reframe Its Investment Story - simplywall.st
Nasdaq 100 Stock Outlook 2026: DexCom vs. Comcast & Warner Bros. DiscoveryNews and Statistics - IndexBox
Champlain Investment Partners LLC Decreases Stake in DexCom, Inc. $DXCM - MarketBeat
Here's How Much You Would Have Made Owning DexCom Stock In The Last 10 Years - Sahm
Intech Investment Management Reduces DexCom Stake - National Today
Rafferty Asset Management Boosts DexCom Holdings - National Today
Dexcom Launches First Nationwide Search for College Athletes With Diabetes to Join Season Four of Dexcom U - Quantisnow
TD Asset Management Boosts DexCom Stake by 16% - National Today
DexCom, Inc. (DXCM) Stock Analysis: 16.91% Potential Upside Amid Robust Growth Metrics - DirectorsTalk Interviews
DexCom (DXCM) Announces Leadership Transition and Compensation D - GuruFocus
American Century Companies Inc. Reduces DexCom Stake - National Today
Kevin Sayer returns as Dexcom (NASDAQ: DXCM) executive chairman - Stock Titan
DexCom, Inc. $DXCM Shares Sold by American Century Companies Inc. - MarketBeat
TD Asset Management Inc Buys 44,770 Shares of DexCom, Inc. $DXCM - MarketBeat
Dexcom Inc Azioni (DXCM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):